These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29762764)

  • 21. Evaluation of EEG cyclic alternating pattern during sleep in insomniacs and controls under placebo and acute treatment with zolpidem.
    Terzano MG; Parrino L
    Sleep; 1992 Feb; 15(1):64-70. PubMed ID: 1557595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sleep disorders--what can be done when hypnotics no longer help? Overview and case report].
    Staedt J; Stoppe G; Hajak G; Müller-Struck A; Rüther E
    Fortschr Neurol Psychiatr; 1995 Sep; 63(9):368-72. PubMed ID: 7590562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling sleep data for a new drug in development using markov mixed-effects models.
    Kjellsson MC; Ouellet D; Corrigan B; Karlsson MO
    Pharm Res; 2011 Oct; 28(10):2610-27. PubMed ID: 21681607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo.
    Roth T; Roehrs T; Vogel G
    Sleep; 1995 May; 18(4):246-51. PubMed ID: 7618022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polygraphical sleep recordings in insomniac patients under zopiclone or nitrazepam.
    Jovanovic UJ; Dreyfus JF
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():136-45. PubMed ID: 7188371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of acute administration of brotizolam in subjects with disturbed sleep.
    Roehrs T; Zorick F; Koshorek GL; Wittig R; Roth T
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):371S-376S. PubMed ID: 6661383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
    Krystal AD; Erman M; Zammit GK; Soubrane C; Roth T;
    Sleep; 2008 Jan; 31(1):79-90. PubMed ID: 18220081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T; Soubrane C; Titeux L; Walsh JK;
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia.
    Walsh JK; Pollak CP; Scharf MB; Schweitzer PK; Vogel GW
    Clin Neuropharmacol; 2000; 23(1):17-21. PubMed ID: 10682226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of placebo administration on the first-night effect in healthy young volunteers.
    Suetsugi M; Mizuki Y; Yamamoto K; Uchida S; Watanabe Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):839-47. PubMed ID: 17328999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant.
    Herring WJ; Snyder E; Budd K; Hutzelmann J; Snavely D; Liu K; Lines C; Roth T; Michelson D
    Neurology; 2012 Dec; 79(23):2265-74. PubMed ID: 23197752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial.
    Morin CM; Koetter U; Bastien C; Ware JC; Wooten V
    Sleep; 2005 Nov; 28(11):1465-71. PubMed ID: 16335333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zolpidem for persistent insomnia in SSRI-treated depressed patients.
    Asnis GM; Chakraburtty A; DuBoff EA; Krystal A; Londborg PD; Rosenberg R; Roth-Schechter B; Scharf MB; Walsh JK
    J Clin Psychiatry; 1999 Oct; 60(10):668-76. PubMed ID: 10549683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose determinants of rebound insomnia.
    Roehrs TA; Zorick FJ; Wittig RM; Roth T
    Br J Clin Pharmacol; 1986 Aug; 22(2):143-7. PubMed ID: 3530302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans.
    Morgan PT; Kehne JH; Sprenger KJ; Malison RT
    J Sleep Res; 2010 Mar; 19(1 Pt 2):157-64. PubMed ID: 19682231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A postmarketing surveillance study of zopiclone in insomnia.
    Mahendran R; Chee KT; Peh LH; Wong KE; Lim L
    Singapore Med J; 1994 Aug; 35(4):390-3. PubMed ID: 7899899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative 25-night sleep laboratory study on the effects of quazepam and triazolam on chronic insomniacs.
    Mamelak M; Csima A; Price V
    J Clin Pharmacol; 1984; 24(2-3):65-75. PubMed ID: 6143767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of placebo and no-treatment during a hypnotic clinical trial.
    Mccall WV; Perlis ML; Tu X; Groman AE; Krystal A; Walsh JK
    Int J Clin Pharmacol Ther; 2005 Aug; 43(8):355-9. PubMed ID: 16119510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APD125, a selective serotonin 5-HT(2A) receptor inverse agonist, significantly improves sleep maintenance in primary insomnia.
    Rosenberg R; Seiden DJ; Hull SG; Erman M; Schwartz H; Anderson C; Prosser W; Shanahan W; Sanchez M; Chuang E; Roth T
    Sleep; 2008 Dec; 31(12):1663-71. PubMed ID: 19090322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of brotizolam on the sleep of chronic insomniacs.
    Mamelak M; Csima A; Price V
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):377S-382S. PubMed ID: 6661384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.